Market Cap

Galapagos NV Market Capitalization:

€1.62 Billion

EUR as of July 1, 2025

US$1.91 Billion

business Galapagos NV Company Profile

Galapagos NV Main Stock Listing

Euronext: GLPGA

Market Capitalization History of Galapagos NV

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Galapagos NV market cap

Date Market Cap YoY Change
Jan. 1, 2025 €1.49 B -40.64%
Jan. 1, 2024 €2.50 B -8.90%
Jan. 1, 2023 €2.75 B -30.08%
Jan. 1, 2022 €3.93 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Galapagos NV Categories

Belgium languages Healthcare languages Biotechnology
Belgium Healthcare Belgium Biotechnology

Stocks & Indices

Galapagos NV has the following listings and related stock indices.


Stock: Euronext: GLPGA

Stock: FSX: GXE

Stock: NASDAQ: GLPG

Stock: MTA: GXE

Stock: XETR: GXE

Stock: OTC: GLPGF

Stock: FSX: GXEA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.